Nutromics
PrivateLast Round
Acceleration Round
Sep 2, 2025
Total Funding Raised
$18.13M
Momentum Score
25 /100
Company Overview
Nutromics is a healthcare technology company that develops medical-grade diagnostics equipment utilizing a DNA-based sensor platform to provide continuous monitoring of biomarkers for diet, sleep, stress, and exercise, empowering patients to make informed lifestyle changes and reduce the risk of diabetes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Health IoT, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nutromics Comps
Public and private peers based on sector, stage, and business model.
Nutromics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Acceleration Round | Sep 2, 2025 | ||||
| Grant | Apr 27, 2024 | ||||
| VC Round | Jun 8, 2023 | ||||
| Seed | Sep 8, 2022 | ||||
| Grant | Sep 29, 2021 | ||||
Seed | Aug 27, 2021 |
Key People
Founding team and executive leadership
Nutromics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Grant |
| The Actuator | Pre Seed |
| Dexcom Ventures | Seed |
| Artesian | Pre Seed, Seed |
| VU Venture Partners | Seed |
| Australian Federal Government (Cooperative Research Centres Projects grant) | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 7, 2026
Thomas M. Prescott appointed as chair of the board.
- Sep 2, 2025
$4.89M raised in an Acceleration Round.
Nutromics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nutromics's valuation, stock price, and market status.
